CNTA
Centessa Pharmaceuticals PLC ADR
NASDAQ: CNTA · HEALTHCARE · BIOTECHNOLOGY
$39.45
-0.03% today
Updated 2026-04-29
Market cap
$6.10B
P/E ratio
—
P/S ratio
406.76x
EPS (TTM)
$-1.46
Dividend yield
—
52W range
$11 – $40
Volume
3.0M
Centessa Pharmaceuticals PLC ADR (CNTA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $19.73M | $11.72M | $629.63M | $444.31M | $360.25M | $576.80M |
| Cash & equivalents | — | $7.23M | $595.08M | $393.64M | $128.03M | $383.22M |
| Current assets | $19.23M | $11.16M | $628.77M | $437.75M | $315.09M | $536.41M |
| Total liabilities | $6.07M | $8.62M | $138.08M | $108.14M | $124.00M | $175.25M |
| Current liabilities | $1.93M | $8.62M | $24.64M | $38.34M | $39.38M | $58.00M |
| Long-term debt | $3.62M | — | $75.70M | $69.80M | $75.70M | $108.94M |
| Shareholder equity | $13.66M | $3.10M | $491.55M | $336.17M | $236.24M | $401.55M |
| Retained earnings | $-12.51M | $-23.84M | $-385.65M | $-601.86M | $-752.95M | $-988.70M |
| Accounts receivable | — | $2.93M | $16.81M | $26.72M | $39.15M | $45.30M |
| Inventory | — | $1.00M | $-17.81M | $-29.99M | $1.00 | — |
| Goodwill | — | — | — | — | — | — |